Background: The Lymphoblastic leukemia 1 (LYL1) gene is a proto-oncogenic transcription factor found upregulated in patients with T-cell acute lymphoblastic leukemia (T-cell ALL). Initially, the upregulation was described to be as a result of a translocation. However, further studies revealed that transcriptional upregulation of LYL1could also occur without translocations. In addition, post-translational mechanisms, such as protein degradation could influence LYL1 expression as well.
Methodology/principal Findings: In this study, we considered possible post-translational regulation of Lyl1, and investigated fundamental mechanisms governing LYL1 degradation in cell-based culture assays. We identify a PEST sequence motif located in the N-terminus of LYL1, which determines the efficiency of LYL1 degradation by the proteasome. The absence of the PEST degradation site leads to accumulation or upregulation of LYL1. We also show that LYL1 is phosphorylated by MAPK at S36, and determined that proteasomal degradation of LYL1 occurs in a phosphorylation-independent manner.
Conclusions/significance: Understanding LYL1 degradation is a step forward not only towards deciphering the normal function and regulation of LYL1, but could suggest post-translational mechanisms for upregulation of LYL1 that may contribute to its oncogenic role.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937031 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012692 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Functional circuits of LYL1 controlled by supraphysiological androgen in prostate cancer cells to regulate cell senescence.
Cell Commun Signal
December 2024
Institute of Human Genetics, Jena University Hospital, Am Klinikum 1, 07740, Jena, Germany.
Background: Prostate cancer (PCa) is a public health problem mostly reported in developed countries. The androgen receptor (AR) regulates the development and physiological function of normal prostate as well as the proliferation of cancerous prostate tissue. Treatment with supraphysiological androgen levels (SAL) is used in bipolar androgen therapy and inhibits PCa growth, suggesting SAL induces a tumor suppressive program.
View Article and Find Full Text PDFInduction of Thymus Atrophy and Disruption of Thymocyte Development by Fipronil through Dysregulation of IL-7-Associated Genes.
Chem Res Toxicol
September 2024
School of Veterinary Medicine, National Taiwan University, Taipei 106, Taiwan.
The susceptibility of the immune system to immunotoxic chemicals is evident, particularly in the thymus, a vital primary immune organ prone to atrophy due to exposure to toxicants. Fipronil (FPN), a widely used insecticide, is of concern due to its potential neurotoxicity, hepatotoxicity, and immunotoxicity. Our previous study showed that FPN disturbed the antigen-specific T-cell functionality .
View Article and Find Full Text PDFMolecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols.
Leukemia
June 2024
Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.
In contrast to B-cell precursor acute lymphoblastic leukemia (ALL), molecular subgroups are less well defined in T-lineage ALL. Comprehensive studies on molecular T-ALL subgroups have been predominantly performed in pediatric ALL patients. Currently, molecular characteristics are rarely considered for risk stratification.
View Article and Find Full Text PDFLoss of thymocyte competition underlies the tumor suppressive functions of the E2a transcription factor in T-ALL.
Leukemia
March 2024
Committee on Immunology, University of Chicago, Chicago, IL, 60637, USA.
T lymphocyte acute lymphoblastic leukemia (T-ALL) is frequently associated with increased expression of the E protein transcription factor inhibitors TAL1 and LYL1. In mouse models, ectopic expression of TAL1 or LYL1 in T cell progenitors, or inactivation of E2A, is sufficient to predispose mice to develop T-ALL. How E2A suppresses thymocyte transformation is currently unknown.
View Article and Find Full Text PDFGenome-wide transcription factor-binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs.
Blood
October 2023
School of Clinical Medicine, University of New South Wales, Sydney, Australia.
Article Synopsis
- Hematopoietic stem and progenitor cells (HSPCs) require a specific combination of seven transcription factors (TFs) to manage their differentiation into various blood cell types, but their precise roles are still unclear.
- The study used advanced techniques to analyze chromatin interactions and TF binding in different HSPC subtypes, revealing that TF activity and enhancer-promoter interactions differ significantly among these cell types, which correlates with how genes are expressed.
- Findings indicate that certain TF combinations are linked to specific blood cell lineages, and these combinations may also prime regulatory regions for future binding by lineage-specific TFs, providing insights into both normal blood cell formation and potential disruption in leukemia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!